Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences
sectors.
Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions.
Website:www.abingworth.com
Industries:
Biotechnology
Health Care
Medical
Pharmaceutical
Biopharma
Therapeutics
Clinical Trials
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
London, England, United Kingdom